Intravitreal injection of TA-III with sustained release to simultaneously impart anti-inflammatory, antioxidative, and vascular remodeling activities in diabetic retinopathy
2025 · Materials & Design · 1 citations
https://doi.org/10.1016/j.matdes.2025.113832